ML Capital Group Acquires Stake in Colorado Highlife Tours Bolstering $1 Million 2017 Cannabis Tours Forecast

Thursday, February 23, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MIAMI, February 23, 2017 /PRNewswire/ --

ML Capital Group, Inc. (USOTC: MLCG) today announced acquiring a twenty-five

percent stake in Colorado Highlife Tours, a Colorado-based cannabis tourism company. MLCG recently announced a strategic plan in partnership with Puration, Inc. (USOTC: PURA) to enter Colorado's
$19 billion
tourism industry with a luxury cannabis tours product. The Colorado Highlife Tours acquisition announced today is intended to accelerate MLCG's Colorado luxury cannabis tourism strategy.

MLCG $1 Million 2017 Sales Forecast and Potential Upward Revision 

MLCG recently released a preliminary $1 million 2017 sales forecast based on the Company's fourth quarter record sales and nearly $400,000 in historical annual revenue earned prior to its record fourth quarter sales. Given the existing revenue and ongoing business momentum that Colorado Highlife Tours brings to MLCG, the management anticipates revising the 2017 revenue forecast upwards after the close of the first fiscal quarter.

CLICK HERE TO LEARN MORE ABOUT MLCG'S LUXURY CANNABIS TOURS

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

ML Capital: info@mlcginc.com +1-786-313-3206

SOURCE ML Capital Group, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook